BRAIN CANCER
Clinical trials for BRAIN CANCER explained in plain language.
Never miss a new study
Get alerted when new BRAIN CANCER trials appear
Sign up with your email to follow new studies for BRAIN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain metastases? study tests pembrolizumab combo
Disease control TerminatedThis study looked at whether adding the drug pembrolizumab to chemotherapy could help people with a type of lung cancer that has spread to the brain but isn't causing symptoms. The goal was to control the cancer in the brain and body while keeping quality of life. Only 3 people t…
Matched conditions: BRAIN CANCER
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer that had returned after standard treatments. The trial aimed to see if VAL-083 could help patients live longer. However, the study was stopped early after only 2 people enrolled, s…
Matched conditions: BRAIN CANCER
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:46 UTC
-
Brain tumor study looks at tiny molecule as possible clue
Knowledge-focused TerminatedThis study looked at a tiny molecule called microRNA-10b in people with brain tumors called gliomas. Researchers wanted to see if higher levels of this molecule could help predict how the disease might progress or how long patients might live. The study was stopped early, but it …
Matched conditions: BRAIN CANCER
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:16 UTC